XBiotech, Inc.
(NASDAQ : XBIT)

( )
XBIT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 0.58%62.991.0%$429.08m
AMGNAmgen, Inc. 0.84%239.591.3%$418.87m
BIIBBiogen, Inc. 0.46%288.501.4%$364.64m
ILMNIllumina, Inc. -0.10%328.003.5%$323.24m
VRTXVertex Pharmaceuticals, Inc. -0.78%233.991.9%$273.36m
REGNRegeneron Pharmaceuticals, Inc. 0.51%365.552.6%$218.36m
EXASEXACT Sciences Corp. 0.82%86.6024.0%$198.72m
ITCIIntra-Cellular Therapies, Inc. 0.28%25.509.0%$173.94m
ALXNAlexion Pharmaceuticals, Inc. -0.23%113.012.0%$173.06m
INCYIncyte Corp. -2.30%78.652.5%$135.12m
SRPTSarepta Therapeutics, Inc. -0.93%121.8514.6%$131.81m
AAgilent Technologies, Inc. -0.56%89.621.6%$120.06m
BMRNBioMarin Pharmaceutical, Inc. -0.82%87.554.3%$106.16m
BLUEbluebird bio, Inc. -2.26%95.8214.2%$95.27m
SGENSeattle Genetics, Inc. -0.30%108.676.1%$90.33m

Company Profile

XBiotech, Inc. is a biopharmaceutical company, which engages in development and commercialization of therapeutic antibodies based on its True Humanâ„¢ proprietary technology. Its product pipeline include oncology, infectious diseases, dermatology, and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.